Wuhan Keqian Biology Co.,Ltd (688526.SS)
CNY 15.75
(-1.69%)
CNY 15.75
(-1.69%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 580 Million CNY | 14.55% |
| 2022 | 569.89 Million CNY | -18.27% |
| 2021 | 638.34 Million CNY | 29.21% |
| 2020 | 557.46 Million CNY | 95.3% |
| 2019 | 290.23 Million CNY | -37.7% |
| 2018 | 465.87 Million CNY | 18.61% |
| 2017 | 382.26 Million CNY | 66.66% |
| 2016 | 214.06 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 125.08 Million CNY | 23.43% |
| 2024 Q1 | 103.59 Million CNY | 70.77% |
| 2024 Q2 | 73.7 Million CNY | -21.5% |
| 2023 Q4 | 116.93 Million CNY | -29.5% |
| 2023 FY | - CNY | 14.55% |
| 2023 Q3 | 165.86 Million CNY | 28.06% |
| 2023 Q2 | 129.52 Million CNY | -18.93% |
| 2023 Q1 | 159.77 Million CNY | -0.54% |
| 2022 FY | - CNY | -18.27% |
| 2022 Q3 | 151.14 Million CNY | 80.85% |
| 2022 Q2 | 83.57 Million CNY | -21.23% |
| 2022 Q1 | 106.1 Million CNY | -51.61% |
| 2022 Q4 | 160.64 Million CNY | 6.29% |
| 2021 Q2 | 134.03 Million CNY | -33.14% |
| 2021 Q1 | 200.48 Million CNY | 32.89% |
| 2021 FY | - CNY | 29.21% |
| 2021 Q4 | 219.27 Million CNY | 87.95% |
| 2021 Q3 | 116.66 Million CNY | -12.96% |
| 2020 FY | - CNY | 95.3% |
| 2020 Q4 | 150.85 Million CNY | -5.15% |
| 2020 Q1 | 109.88 Million CNY | 148.49% |
| 2020 Q2 | 110.55 Million CNY | 0.62% |
| 2020 Q3 | 159.04 Million CNY | 43.85% |
| 2019 Q2 | 82.85 Million CNY | -3.23% |
| 2019 Q1 | 85.61 Million CNY | 0.0% |
| 2019 Q4 | 44.22 Million CNY | 1.4% |
| 2019 Q3 | 43.6 Million CNY | -47.37% |
| 2019 FY | - CNY | -37.7% |
| 2018 FY | - CNY | 18.61% |
| 2017 FY | - CNY | 66.66% |
| 2016 FY | - CNY | 0.0% |